NASDAQ:XBIO | Cash Flow Statement | Xenetic Biosciences, Inc.

Complete source-backed cash-flow history.

Available history
2011-11-30 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$929,695.00
2026-03-31-$456,382.00-$536,377.00
2025-12-31-$579,076.00-$242,682.00
2025-09-30-$509,940.00
2025-06-30-$688,703.00
2025-03-31-$903,141.00-$1M
2024-12-31-$1.05M-$673,992.00
2024-09-30-$436,671.00
2024-06-30-$1.27M
2024-03-31-$1.2M-$1.16M
2023-12-31-$1.17M-$793,027.00$0.00
2023-09-30-$1.06M
2023-06-30-$1.05M
2023-03-31-$856,554.00-$1.1M
2022-12-31-$1.48M-$750,907.00$0.00$0.00
2022-09-30-$804,017.00
2022-06-30-$2.67M
2022-03-31-$1.59M-$2.09M
2021-12-31-$1.84M-$1.46M$0.00$0.00
2021-09-30-$1.35M
2021-06-30-$1.11M
2021-03-31-$1.35M-$1.52M
2020-12-31-$1.2M-$953,660.00$0.00$5.43M
2020-09-30-$7.56M
2020-06-30-$953,642.00
2020-03-31-$1.18M-$1M$0.00$0.00
2019-12-31-$1.17M-$1.68M$0.00$1,200.00
2019-09-30-$8.9M
2019-06-30-$1.38M
2019-03-31-$1.33M-$1.25M$2,000.00$2.7M
2018-12-31-$1.64M-$1.04M$0.00$0.00$0.00
2018-09-30-$1.81M
2018-06-30-$2.03M
2018-03-31-$1.82M-$1.67M$0.00$0.00$0.00
2017-12-31$4.45M$4.84M$0.00$0.00$0.00
2017-09-30-$2.26M
2017-06-30-$2.92M
2017-03-31-$2.87M$280,809.00$5,429.00-$5,429.00$0.00
2016-12-31-$391,328.00-$4.62M$2,180.00-$2,180.00$8.46M
2016-09-30-$2.47M
2016-06-30-$47.77M
2016-03-31-$3.57M$9,082.00-$1.77M$14,613.00
2015-12-31-$3.63M$8,643.00-$1.12M$0.00
2015-09-30-$5.32M
2015-06-30-$1.13M
2015-03-31-$2.43M$163,289.00-$2.04M$0.00
2014-12-31-$4.3M-$2.66M$11,660.00
2014-09-30-$3.18M
2014-06-30-$2.76M
2014-03-31-$4.06M-$4.12M$16,992.00
2013-12-31-$3.54M-$2.01M$63,830.00
2013-11-30-$82,462.00-$173,144.00$212,500.00$160,000.00
2013-09-30-$2.73M
2013-08-31-$76,090.00$250,431.00$0.00
2013-06-30-$938,331.00
2013-03-31-$1.38M-$942,281.00$4,090.00
2012-11-30-$14,479.00$212,500.00
2012-08-31-$2,881.00-$1,051.00$0.00
2011-11-30-$18,169.00-$1,825.00

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$2.68M-$2.29M$4M
2024-12-31-$3.96M-$2.82M$0.00
2023-12-31-$4.13M-$4.11M$0.00
2022-12-31-$6.55M-$4.65M-$500,000.00$0.00
2021-12-31-$5.65M-$4.74M$0.00$11.45M
2020-12-31-$10.89M-$4.27M$0.00$5.43M
2019-12-31-$12.78M-$6.4M$2,000.00$16.13M
2018-12-31-$7.3M-$6.46M$0.00$22,500.00$1.48M
2017-12-31-$3.6M$1.49M$9,264.00-$9,264.00$0.00
2016-12-31-$54.21M-$8.79M$16,793.00-$16,793.00$12.72M
2015-12-31-$12.51M$56,115.00-$5.3M$1,663.00
2014-12-31-$14.31M$88,689.00-$12.68M$57,669.00
2013-12-31-$8.58M-$6.05M$78,634.00-$144,634.00$2,090.00
2013-08-31-$89,172.00$280,609.00$212,500.00-$259,392.00
2012-12-31-$6.33M-$6.26M$130,084.00-$92,586.00-$303,352.00
2012-08-31-$89,172.00-$12,995.00$35,000.00

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.